List view / Grid view
In a breakthrough study, scientists have identified a key food allergen behind eosinophilic esophagitis (EoE), offering new hope for diagnosis and treatment advancements.
In the latest instalment of Recall Roundup (24-30 January 2025), New Food highlights recent food and beverage recalls in the UK and US.
Coeliac UK's new report shows progress in gluten-free dining, but highlights ongoing challenges and the need for safer, more inclusive options.
In the latest instalment of Recall Roundup (17-23 January 2025), New Food highlights recent food and beverage recalls in the UK and US.
In the latest instalment of Recall Roundup (10-16 January 2025), New Food highlights recent food and beverage recalls in the UK and US.
In the latest instalment of Recall Roundup (3-9 January 2025), New Food highlights recent food and beverage recalls in the UK and US.
FDA's new guidance aims to improve plant-based food labelling, ensuring clarity and transparency for consumers choosing animal product alternatives.
The EU has approved Magtein as a novel food, granting exclusive rights to its market in the region for five years.
In this week's episode, Assistant Editor Ben Cornwell sits down with Karthik Kondepudi, Partner at Herbochem to discuss the emerging trends shaping the nutraceutical industry.
In the latest instalment of Recall Roundup (22-28 November 2024), New Food highlights recent food and beverage recalls in the UK and US.
Tate & Lyle's new report reveals nine key trends, providing insights for brands and manufacturers to innovate and optimise food texture.
A new study highlights effective methods for reducing pathogens in pecans, ensuring safety for Thanksgiving pies and other treats.
Arla Foods partners with Morrisons, Tesco, and Aldi to trial Bovaer® feed additive, aiming to reduce methane emissions in dairy farming.
In the latest instalment of Recall Roundup (15-21 November 2024), New Food highlights recent food and beverage recalls in the UK and US.
A cocoa-flavoured soy drink enriched with edible bird’s nest hydrolysates shows promising functional benefits for managing hypertension, diabetes and satiety.
